Post-operative Cesarean Trial of Pain Control

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 7, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Post-operative PainCesarean Section
Interventions
DEVICE

ON-Q Pump® with continuous infusion of bupivacaine

270 ml of 0.5 % bupivacaine. The device being used is a fixed flow pump meaning the rate of 2 mL/hour. The pump is connected to the catheter and left in place for up to 4 post-operative days or until the completion of the infusion.

DEVICE

ON-Q Pump® with continuous infusion of saline

270 mL of normal saline. The device being used is a fixed flow pump meaning the rate of 2 mL/hour. The pump is connected to the catheter and left in place for up to 4 post-operative days or until the completion of the infusion.

Trial Locations (1)

80011

RECRUITING

Children's Hospital Colorado, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Avanos Medical

OTHER

collaborator

Children's Hospital Colorado

OTHER

collaborator

Colorado Fetal Care Center

UNKNOWN

lead

University of Colorado, Denver

OTHER